MedPath

Efficacy of BoNT-A treatment in patients with Awake Bruxism and Temporomandibular Disorder (TMD)

Phase 2
Conditions
Bruxism
C05.500.607.221.897.897
Registration Number
RBR-62cftbp
Lead Sponsor
Faculdade de Odontologia da Universidade do Estado do Rio de Janeiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Volunteers of both genders; aged between 18 and 60 years; with Temporomandiibular Disorders; With high frequency of awake bruxism activity

Exclusion Criteria

Volunteers with facial and Temporomanbular Joint trauma; using full dentures or removable partial dentures; ongoing orthodontic treatment; blood dyscrasia patients; with presence of arthritis; arthrosis; diabetes; neurological pathologies; fibromyalgia; who received tetanus vaccine or botulinum toxin injections in the three months prior to the study

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath